Navigating FDA Challenges and AI Disruptions

This chapter discusses the future of the FDA amid leadership changes and the potential brain drain impacting drug approvals and scientific research. It highlights the implications of immigration policies and funding uncertainties, emphasizing how these factors may stifle innovation in the biotechnology sector. The conversation also touches on Google's challenges within the AI search market, underscoring the urgency for adaptation to maintain its competitive edge.